|
|
|
|
Highlights of the 19th ASNO Annual Meeting Programme
|
|
|
|
Join us at the 19th ASNO Annual Meeting in Singapore from 16 – 18 August 2024, where we will feature a comprehensive programme of cutting-edge presentations, workshops, and networking opportunities. Don't miss out on the latest advancements and collaborative discussions in Neuro-Oncology.
|
|
|
|
|
|
|
 |
|
Ang Beng Ti – Singapore
Senior Consultant, Department of Neurosurgery, National Neuroscience Institute
Plenary 4 | Implementing Precision Medicine in Translational Research
|
|
 |
|
Bala Vellayappan – Singapore
Senior Consultant, National University Cancer Institute
Plenary 3 | Managing Radiation Necrosis
|
|
|
|
|
 |
|
Carol Tang – Singapore
Deputy Director, Innovation, SG Enable (Focal Agency of the Ministry of Social and Family Development)
Identifying Therapeutic Vulnerabilities in Transcriptomic Subtypes of Glioblastoma and Clinical Implementation Using a Nanosensor of Novel Composition
|
|
 |
|
Daniel Teh – Singapore
Assistant Professor, Departments of Ophthalmology, Anatomy and Biomedical Engineering, National University of Singapore
Wireless Photodynamic Therapy in Orthotopic Glioblastoma Mice Model
|
|
|
|
|
 |
|
Jason Chan – Singapore
Medical Oncologist, National Cancer Center
Updates on Management of Primary CNS Lymphoma
|
|
 |
|
Jong Sze Chin – Singapore
Consultant, National University Hospital
NeuroOncology Rehabilitation
|
|
|
|
|
| View Full Programme |
|
*We will be featuring our speakers regularly in future mailers.
|
 |
|
The 19th ASNO Annual Meeting is a must-attend event due to its comprehensive coverage of cutting-edge topics in neuro-oncology. The sessions will delve into crucial topics such as IDH – Mutant Low Grade Glioma, Glioblastoma - IDH Wild Type, providing invaluable insights into tumour surgery, current practices, and future trends over the next 20 years. You'll gain a deep understanding of cutting-edge neuro-oncology practices in Asia, including advancements in radiation oncology, survivorship, nursing care, and the management of brain/spine metastases. Additionally, the conference will cover the importance of multidisciplinary care, pediatric neuro-oncology, and patient advocacy, making it an indispensable learning adventure for anyone in this field.
|
|
|
|
|
|
|
|
|
|
|
|
Connect with us on LinkedIn for more updates on the exciting programme:
|
|
|
|
|
